Accuracy of cerebrospinal fluid biomarker ratios to determine amyloid positron‐emission tomography status: a diagnostic test accuracy meta‐analysis
All three CSF biomarker ratios (Aβ42/Aβ40, pTau/Aβ42, and tTau/Aβ42) analyzed were highly concordant with amyloid PET. However, the pTau/Aβ42 ratio consistently showed higher concordance with amyloid PET positivity than the Aβ42/Aβ40 or tTau/Aβ42 ratio across multiple analysis methods, suggesting that pTau/Aβ42 may be the preferred CSF biomarker ratio for confirmation of the diagnosis of AD.
Authors
- Eino Solje (ORCID: https://orcid.org/0000-0001-9940-9524)
- Julian G Martins
- Sraboni Sarkar
- Pablo Martínez‐Lage
Institutions
- Springer Nature (Germany) (DE)
- University of Eastern Finland (FI)
- Rotary International (US)
- Kuopio University Hospital (FI)
- Eastern Finland Laboratory Center (FI)
- Fundacion CITA Alzheimer (ES)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70856_100941
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00